B.J. (Byungji) Kim leads the Kimmunity with a focus on developing cutting-edge RNA-based therapeutics and immunoengineering tools for cancer, vaccines, and drug delivery. She earned her Ph.D. in Materials Science and Engineering from UC San Diego with Prof. Michael J. Sailor, where she gained expertise in RNA delivery. As a postdoctoral associate at MIT with Prof. Darrell J. Irvine, she addressed immunological barriers to RNA vaccines and developed next-generation RNA delivery systems for cancer treatment. Her multidisciplinary research blends materials science, immunology, and bioengineering to tackle some of the most pressing challenges in therapeutic development for clinical translation.